- Home
- Publications
- Publication Search
- Publication Details
Title
Osteoblastogenesis and tumor growth in myeloma
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 51, Issue 2, Pages 213-220
Publisher
Informa UK Limited
Online
2010-06-18
DOI
10.3109/10428190903503438
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Eph Receptors and Ephrin Signaling Pathways: A Role in Bone Homeostasis
- (2012) Claire M. Edwards et al. International Journal of Medical Sciences
- Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption
- (2010) Taina Taube et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo
- (2009) Claire M. Edwards et al. AMERICAN JOURNAL OF HEMATOLOGY
- Aurora kinase A is a target of Wnt/ -catenin involved in multiple myeloma disease progression
- (2009) J. Dutta-Simmons et al. BLOOD
- The ephrinB2/EphB4 axis is dysregulated in osteoprogenitors from myeloma patients and its activation affects myeloma bone disease and tumor growth
- (2009) A. Pennisi et al. BLOOD
- Bortezomib induces osteoblast differentiation via Wnt-independent activation of -catenin/TCF signaling
- (2009) Y.-W. Qiang et al. BLOOD
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- (2009) O. Landgren et al. BLOOD
- Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
- (2009) M. Fulciniti et al. BLOOD
- Growth factor control of bone mass
- (2009) Ernesto Canalis JOURNAL OF CELLULAR BIOCHEMISTRY
- Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors
- (2009) M Garayoa et al. LEUKEMIA
- The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo
- (2008) Angela Pennisi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Role of decorin in the antimyeloma effects of osteoblasts
- (2008) X. Li et al. BLOOD
- Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth
- (2008) Y.-W. Qiang et al. BLOOD
- Myeloma-derived Dickkopf-1 disrupts Wnt-regulated osteoprotegerin and RANKL production by osteoblasts: a potential mechanism underlying osteolytic bone lesions in multiple myeloma
- (2008) Y.-W. Qiang et al. BLOOD
- The role of Dickkopf-1 in bone development, homeostasis, and disease
- (2008) J. J. Pinzone et al. BLOOD
- Eph-Ephrin Bidirectional Signaling in Physiology and Disease
- (2008) Elena B. Pasquale CELL
- Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma
- (2008) Martin Kaiser et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs
- (2008) Silvia Goldoni et al. INTERNATIONAL JOURNAL OF CANCER
- EphrinB2 Regulation by PTH and PTHrP Revealed by Molecular Profiling in Differentiating Osteoblasts
- (2008) Elizabeth H Allan et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma
- (2008) Deborah J Heath et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The cell biology of bone metabolism
- (2008) H K Datta et al. JOURNAL OF CLINICAL PATHOLOGY
- Bone marrow microenvironment and the identification of new targets for myeloma therapy
- (2008) K Podar et al. LEUKEMIA
- Pathogenesis of myeloma bone disease
- (2008) G D Roodman LEUKEMIA
- Decorin-Induced Growth Inhibition Is Overcome through Protracted Expression and Activation of Epidermal Growth Factor Receptors in Osteosarcoma Cells
- (2008) A. Zafiropoulos et al. MOLECULAR CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now